SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

ANX i like this!! anyone see that gap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
semipro11 Member Profile
 
Followed By 308
Posts 25,529
Boards Moderated 2
Alias Born 04/04/08
160x600 placeholder
Results of Vepoloxamer Nonclinical Studies in Advanced Heart Failure Presented at European Society of Cardiology 3rd World Co... "PR Newswire (US)" - 5/23/2016 8:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/17/2016 6:01:31 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/17/2016 6:00:53 AM
Positive Interim Results From Second Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction... "PR Newswire (US)" - 5/16/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 5/16/2016 7:42:09 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/13/2016 5:34:31 PM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/6/2016 4:36:33 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/6/2016 9:05:31 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/6/2016 8:17:12 AM
Mast Therapeutics Reports First Quarter 2016 Financial Results And Recent Highlights "PR Newswire (US)" - 5/6/2016 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/28/2016 4:30:09 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/28/2016 4:22:06 PM
Mast Therapeutics Announces Agreement For Phase 2 Study Of AIR001 To Be Conducted By The Heart Failure Clinical Research Netw... "PR Newswire (US)" - 4/13/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2016 5:01:40 PM
Results Of Vepoloxamer Nonclinical Studies In Advanced Heart Failure Presented At American College Of Cardiology 65th Annual ... "PR Newswire (US)" - 4/4/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/25/2016 5:05:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/14/2016 8:21:40 AM
Mast Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results "PR Newswire (US)" - 3/14/2016 8:00:00 AM
Mast Therapeutics To Present At Cowen And Company 36th Annual Health Care Conference On March 7th "PR Newswire (US)" - 3/1/2016 8:00:00 AM
Mast Announces Amendment To Loan And Security Agreement With Hercules Capital "PR Newswire (US)" - 2/29/2016 8:00:00 AM
Mast Therapeutics Completes Patient Enrollment In Pivotal Phase 3 "EPIC" Study For The Treatment Of Sickle Cell Crisis "PR Newswire (US)" - 2/22/2016 5:00:00 AM
Mast Therapeutics Closes $8 Million Public Offering "PR Newswire (US)" - 2/16/2016 4:15:00 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/12/2016 1:20:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/11/2016 6:14:49 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/11/2016 6:14:10 AM
semipro11   Wednesday, 03/21/12 11:27:13 AM
Re: Tommy post# 9617
Post # of 13952 
ANX i like this!! anyone see that gap to the 90's weeeeeeeeee

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist